3Shibata S,Chow W,Frankel P,et al.A phase I study of oxaliplatin in combination with gemcitabine:correlation of clinical outcome with gene expression[J].Cancer Chemother Pharmacol,2007;59(4):549-57.
4Maffei S,Mercuri A,Zucchelli GC,et al.Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women[J].Int J Cardiol,2006;107(2):194-9.
5Topcuoglu A,Uzun H,Aydin S,et al.The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women[J].Tohoku J Exp Med,2005;205(11):79-86.
6Barrett CE,Laakso M.Ischemic heart disease risk in postmenopausal women.Effects of estrogen use on glucose and insulin levels[J].Arteriosclerosis,1990,10(7/8):531-534.
7Barrett CE,Wingard DL,Criqui MH.Postmenopausal estrogen use and heart disease risk factors in the 1980s.Rancho Bernardo,Calif,revisited[J].JAMA,1989,261(14):2095-2100.
8Nabulsi AA,Folsom AR,White A,et al.Association of hormone-replacement therapy with various cardiovascular fisk factors in postmenopausal women[J].N Engl J Med,1993,328(15):1069-1075.
